TELA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Tela Bio Inc is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock has weak financial performance, declining analyst price targets, and no positive trading signals. Additionally, the technical indicators and options data do not suggest a strong upward trend. It is better to hold off on this investment for now.
The MACD is slightly positive but contracting, RSI is neutral at 45.301, and moving averages are converging, indicating no clear trend. The stock is trading below the pivot level of 0.642, with key support at 0.564 and resistance at 0.72.
Gross margin increased by 3.66% YoY in the latest quarter, showing some operational efficiency.
Revenue growth guidance for 2026 has been significantly reduced from 15% to 8%. Analysts have lowered price targets across the board, reflecting diminished confidence in the company's growth prospects. Financial performance shows declining EPS and net income. No recent news or significant insider or hedge fund activity to indicate positive sentiment.
In Q4 2025, revenue grew by 18.24% YoY to $20.87M, but net income dropped by 1.81% YoY to -$9.04M. EPS fell by 26.09% YoY to -0.17, indicating worsening profitability. Gross margin improved to 65.91%, up 3.66% YoY.
Analysts have lowered price targets significantly, with the highest target now at $3 (previously $5) and the lowest at $1. Analysts maintain Buy or Neutral ratings but express concerns over reduced growth expectations and operational challenges.
